HB 1114 — Maryland

HIV Prevention Drugs - Prescribing, Dispensing, and Insurance Coverage

Authorizing pharmacists to prescribe and dispense preexposure prophylaxis for HIV prevention to patients under certain circumstances; prohibiting managed care organizations, insurers, nonprofit health service plans, and health maintenance organizations from requiring prior authorization for preexposure prophylaxis for HIV prevention or step therapy or cost sharing for preexposure prophylaxis for HIV prevention or postexposure prophylaxis for HIV prevention; etc.

Latest action: Hearing 3/04 at 1:00 p.m. · Feb 11, 2026

In committeeAIDSCommittees and CommissionsDrugsEducationHealth InsuranceHealth Maintenance OrganizationsHealth OccupationsImmunizationJob TrainingManaged Care OrganizationsMedical AssistanceMedical ConditionsMedical Testing and DiagnosisMedical TreatmentsNonprofit OrganizationsNoticesPharmacists and PharmaciesPregnancyPricesPublic HealthRules and Regulations

Synopsis written by the legislature's own staff, as published on the official bill page. Status label is derived from the recorded actions. The full text below is the record.

Committees: Health (House of Delegates)

Updated Mar 17, 2026

Timeline

First Reading Health
Feb 11, 2026 · House of Delegates
Hearing 3/04 at 1:00 p.m.
Feb 11, 2026 · House of Delegates

Sponsored by Gabriel Acevero, Luke Clippinger, Kris Fair, Anne Kaiser, Aaron Kaufman, Joe Vogel, Teresa Woorman, Martinez

No recorded floor votes yet.

Fiscal and Policy Note — official analysis by legislative staff (PDF) Bill text (First reading) — Maryland General Assembly (PDF) Official record — Maryland General Assembly bill page

Official records. Maryland legislators, bills and roll-call votes from the Maryland General Assembly, imported through Open States on Oct 27, 2026 (partial import — not yet the full session). Accuracy review against the official site is still under way. Campaign-finance records for Maryland are not imported yet.